| Name | Title | Contact Details |
|---|---|---|
Claudia Kuri |
Chief Operating Officer | Profile |
Glenn Galloway |
Executive VP Technology & Integrations | Profile |
Fallon Ambulance Service was founded in 1936 by James Fallon Sr. and remains a family operated business to this day. Fallon Ambulance employs more than 525 personnel, including 125 Paramedics and 375 EMTs, and operates 115 vehicles. The company provides
WPS Health Solutions is a nationally regarded government contractor and leader in the insurance industry, serving our communities for more than 70 years. WPS has five divisions committed to delivering high-quality service to our customers. - The WPS Health Insurance division offers affordable health plans for individuals, small businesses, and large businesses, plus benefits administration. - The WPS Government Health Administrators division administers Part A and Part B Medicare benefits—services we have provided since the program`s inception—for millions of seniors in multiple states. - The WPS Military and Veterans Health division serves millions more beneficiaries who are active in the U.S. military, veterans, and their families. - The Arise Health Plan division offers high-value health plans with local service. - The EPIC Specialty Benefits division has offered voluntary non-medical benefits, such as term life, disability, dental, and vision, for more than 25 years. WPS also actively partners with non-profit organizations to help make lasting changes in the communities we serve, with an emphasis on health issues, especially for military and veterans, and women and children.
Putnam Science is a Putnam, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Devereux Advanced Behavioral Health is one of the largest and most advanced behavioral healthcare organizations in the country. Informed by the latest advancements in science and medicine, we combine evidence-based interventions with compassionate family engagement to help change lives. We were founded in 1912 by special education pioneer, Helena Devereux. Today, Devereux is a national nonprofit partner for individuals, families, schools and communities, serving many of the most vulnerable members of our society in areas of autism, intellectual and developmental disabilities, specialty mental health, and child welfare. Our Mission: Devereux Advanced Behavioral Health changes lives – by unlocking and nurturing human potential in people living with emotional, behavioral or cognitive differences. Devereux Advanced Behavioral Health employs more than 7,500 staff and operates 15 centers in 13 states. We offer a comprehensive national network of clinical, therapeutic, educational, and employment programs and services that positively impact the lives of tens of thousands of children, adults – and their families – every year. Our Culture, Our Expectations At Devereux, we strive to incorporate servant leadership into our culture and every aspect of our organizational framework; from the delivery of quality services to individuals served, their families, and other stakeholders to the development and empowerment of our employees. We offer challenging and exciting work, and our supportive team environment creates an empowering and positive atmosphere. To be successful in our work environment, you will put the needs of others first, and will feel called to serve, and called to lead.
BioSig Technologies, Inc. (OTCQB: BSGM) is a medical device company that is developing a proprietary technology platform to address an unmet technology need in the rapidly growing $4.6+ billion electrophysiology (EP) marketplace. Led by a proven management team, world-class Board of Directors and Scientific Advisory Board, Minneapolis-based BioSig Technologies is preparing to commercialize its PURE EP™ System. The PURE EP System is a surface electrocardiogram (ECG) and intracardiac multichannel recording and analysis system designed to assist electrophysiologists in making crucial clinical decisions in real-time by acquiring and displaying high-fidelity cardiac signal recordings even at undetectable levels (until now) with high accuracy to help identify appropriate catheter ablation targets - areas of tissue to destroy that create a heart rhythm disturbance (arrhythmia). BioSig`s main goal is to deliver technology to improve upon catheter ablation treatments for the prevalent and deadly arrhythmias, Atrial Fibrillation and Ventricular Tachycardia. PURE EP is an innovative platform, offering potential benefits over current technologies including increased accuracy, reduced noise and interference, clinical information previously not available and potential elimination of the need for repeat procedures. BioSig has partnered with Minnetronix on technology development and is working toward FDA 510(k) clearance for the PURE EP System.